Insider Trading: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

29.69USD
17 Sep 2014
Price Change (% chg)

$-0.22 (-0.74%)
Prev Close
$29.91
Open
$30.03
Day's High
$30.41
Day's Low
$29.61
Volume
513,883
Avg. Vol
459,888
52-wk High
$39.94
52-wk Low
$27.51

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
19 Aug 2013

COHEN RON

Chief Executive Officer Sell 5,840 $34.82
19 Aug 2013

COHEN RON

Chief Executive Officer Sell 26,105 $34.25
19 Aug 2013

COHEN RON

Chief Executive Officer Buy 31,945 $2.60
19 Aug 2013

COHEN RON

Chief Executive Officer Buy 113,141 $2.60
18 Aug 2013

COHEN RON

Chief Executive Officer Buy 55,993 $2.60
18 Aug 2013

COHEN RON

Chief Executive Officer Sell 55,993 $34.02
15 Aug 2013

COHEN RON

Chief Executive Officer Buy 42,062 $2.60
15 Aug 2013

COHEN RON

Chief Executive Officer Buy 19,000 $2.60
15 Aug 2013

COHEN RON

Chief Executive Officer Sell 61,062 $34.04
1 Aug 2013

KELLEY JOHN P

Director Sell 15,000 $38.00
1 Aug 2013

KELLEY JOHN P

Director Buy 15,000 $16.74
18 Jul 2013

BLIGHT ANDREW R

Officer Buy 19,296 $2.60
18 Jul 2013

BLIGHT ANDREW R

Officer Sell 19,296 $37.82
9 Jun 2013

COHEN RON

Chief Executive Officer Sell 11,000 $34.15
7 May 2013

PANEM SANDRA

Director Buy 10,000 $25.45
7 May 2013

PANEM SANDRA

Director Sell 10,000 $33.80
5 Mar 2013

COHEN RON

Chief Executive Officer Buy 22,500 $0.00
5 Mar 2013

WASMAN JANE

General Counsel Buy 11,258 $0.00
5 Mar 2013

CARRAZANA ENRIQUE J

Officer Buy 8,300 $0.00
5 Mar 2013

BLIGHT ANDREW R

Officer Buy 7,550 $0.00
5 Mar 2013

SABELLA LAUREN M

Officer Buy 7,100 $0.00
5 Mar 2013

LAWRENCE DAVID

Chief Financial Officer Buy 6,093 $0.00
6 Dec 2012

LAWRENCE DAVID

Chief Financial Officer Buy 1 $5.85
3 Dec 2012

SABELLA LAUREN M

Officer Sell 4,364 $24.58
2 Dec 2012

WASMAN JANE

General Counsel Sell 7,019 $24.20

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 236
Total Shares Held: 45,038,616
3 Mo. Net Change: 1,607,427
# New Positions: 33
# Closed Positions: 20
# Increased Positions: 106
# Reduced Positions: 81
# Net Buyers: 25

Officers & Directors

Name Age Since Current Position

Ron Cohen

58 President,Chief Executive Officer, Director

Michael Rogers

54 2013 Chief Financial Officer

Lauren Sabella

53 2010 Executive Vice President - Commercial Development

Andrew Blight

63 2004 Chief Scientific Officer

Jane Wasman

57 2012 President - International, General Counsel, Corporate Secretary

Enrique Carrazana

52 2011 Chief Medical Officer

Andrew Asa Hindman

2014 Chief Business Development Officer

David Lawrence

56 2013 Chief - Business Operations

Barry Greene

50 2007 Independent Director

Peder Jensen

59 2011 Independent Director

John Kelley

60 2008 Independent Director

Sandra Panem

67 1998 Independent Director

Lorin Randall

70 2006 Independent Director

Steven Rauscher

60 2005 Independent Director

Ian Smith

48 2007 Independent Director
Search Stocks